BRIEF-Sanofi Dengvaxia dengue vaccine approved in Brazil

lunes 28 de diciembre de 2015 06:40 GYT

Dec 28 (Reuters) - Sanofi SA :

* Sanofi Pasteur announces that the Brazilian regulatory authorities ANVISA approved, tetravalent dengue vaccine, for the prevention of disease caused by all four dengue types in individuals from 9-45 years of age living in endemic areas Source text for Eikon: Further company coverage: (Gdynia Newsroom)